Patents by Inventor Ruth Wagers

Ruth Wagers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9403905
    Abstract: Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof.
    Type: Grant
    Filed: May 15, 2014
    Date of Patent: August 2, 2016
    Assignee: HUMAN GENOME SCIENCES, INC.
    Inventors: Craig Rosen, Vivian Albert, Steven M. Ruben, Ruth Wager
  • Publication number: 20140342405
    Abstract: Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof.
    Type: Application
    Filed: May 15, 2014
    Publication date: November 20, 2014
    Applicant: Human Genome Sciences, Inc.
    Inventors: Craig Rosen, Vivian Albert, Steven M. Ruben, Ruth Wager
  • Patent number: 8784809
    Abstract: Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof.
    Type: Grant
    Filed: January 24, 2013
    Date of Patent: July 22, 2014
    Assignee: Human Genome Sciences, Inc.
    Inventors: Craig Rosen, Vivian Albert, Steven M. Ruben, Ruth Wager
  • Publication number: 20130309232
    Abstract: Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof.
    Type: Application
    Filed: January 24, 2013
    Publication date: November 21, 2013
    Applicant: HUMAN GENOME SCIENCES, INC.
    Inventors: Craig Rosen, Vivian Albert, Steven M. Ruben, Ruth Wager
  • Patent number: 7850963
    Abstract: Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof.
    Type: Grant
    Filed: April 3, 2007
    Date of Patent: December 14, 2010
    Assignee: Human Genome Sciences, Inc.
    Inventors: Craig A. Rosen, Vivian R. Albert, Steven M. Ruben, Ruth Wager
  • Publication number: 20070105739
    Abstract: The articles, compositions, and kits of the present invention are useful for conditioning fabric.
    Type: Application
    Filed: December 21, 2006
    Publication date: May 10, 2007
    Inventors: Errol Wahl, Jodi Brown, Lisa Grace, Ruth Wagers, George Deckner, Eric Johnson, Barbara Williams, Jiping Wang, Jean-Pol Boutique, Patrick Deplancke, Francesco de Buzzaccarini, Michele Watkins
  • Publication number: 20070077197
    Abstract: Diagnostic and therapeutic compositions in the form of complexes for enhancing transmembrane transport of a diagnostic or therapeutic agent and methods for their use. The complexes contain the ?, ?, or bis isomers of folate receptor-binding analogs of folate, a metal chelated by a ligand, and in one embodiment, a chemotherapeutic agent.
    Type: Application
    Filed: September 25, 2006
    Publication date: April 5, 2007
    Applicant: Bracco International B.V.
    Inventors: Paul Wedeking, Ruth Wager, Thangavel Arunachalam, Kondareddiar Ramalingam, Karen Linder, Ramachandran Ranganathan, Adrian Nunn, Nataranjan Raju, Michael Tweedle
  • Publication number: 20060217288
    Abstract: The articles, compositions, and kits of the present invention are useful for conditioning fabric.
    Type: Application
    Filed: February 16, 2006
    Publication date: September 28, 2006
    Inventors: Errol Wahl, Jodi Brown, Lisa Brush, Ruth Wagers, George Deckner, Eric Johnson, Barbara Williams, Jiping Wang, Jean-Pol Boutique, Patrick Deplancke, Francesco de Buzzaccarini, Michele Watkins
  • Publication number: 20060122087
    Abstract: Fabric conditioning compositions comprising at least 10% by weight free fatty acid are useful in softening fabrics.
    Type: Application
    Filed: October 20, 2005
    Publication date: June 8, 2006
    Inventors: Errol Wahl, Gerard Baillely, Ruth Wagers, Gayle Frankenbach, Jose Rojo Moreno
  • Publication number: 20050244444
    Abstract: A film-forming composition for use in preparing water-soluble films that are rapidly dissolving under cold water conditions, the composition comprising a water soluble polymer material such as polyvinyl alcohol and a principal solvent, typically diol(s) or derivative of a diol. Films made from the film-forming compositions may be used to encapsulate a variety of compositions for subsequent release into an aqueous medium. Encapsulated compositions can include various laundry detergents and additives, fabric care compositions such as fabric softening compositions and dishwashing detergents among others. When used to encapsulate compositions, the solvent system used in the film-forming composition will have at least one common solvent material as the solvent system used in the encapsulated composition to improve film dissolution and to prevent problems associated with solvent migration.
    Type: Application
    Filed: July 7, 2005
    Publication date: November 3, 2005
    Inventors: Kelly Kochvar, Heidi Soyez, Peter Forth, Jean-Pol Boutique, Ruth Wagers, Errol Wahl, Matthew Lynch, Wayne Fisher
  • Publication number: 20050232921
    Abstract: Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention also relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof.
    Type: Application
    Filed: November 19, 2004
    Publication date: October 20, 2005
    Inventors: Craig Rosen, Vivian Albert, Steven Ruben, Ruth Wager
  • Publication number: 20050192429
    Abstract: Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention also relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof.
    Type: Application
    Filed: November 19, 2004
    Publication date: September 1, 2005
    Inventors: Craig Rosen, Vivian Albert, Steven Ruben, Ruth Wager
  • Publication number: 20050059117
    Abstract: Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof.
    Type: Application
    Filed: November 4, 2004
    Publication date: March 17, 2005
    Applicant: Human Genome Sciences, Inc.
    Inventors: Craig Rosen, Vivian Albert, Steven Ruben, Ruth Wager
  • Publication number: 20030176674
    Abstract: Disclosed are human VEGF-2 antibodies, antibody fragments, or variants thereof. Also provided are processes for producing such antibodies. The present invention relates to methods and compositions for preventing, treating or ameliorating a disease or disorder comprising administering to an animal, preferably a human, an effective amount of one or more VEGF-2 antibodies or fragments or variants thereof.
    Type: Application
    Filed: April 12, 2002
    Publication date: September 18, 2003
    Inventors: Craig A. Rosen, Vivian R. Albert, Steven M. Ruben, Ruth Wager